Skip to main content

Imerys No Longer A Defendant In Upcoming Talc Trial

Imerys No Longer A Defendant In Upcoming Talc Trial

Imerys No Longer A Defendant In Upcoming Talc Trial

Introduction

On Thursday, February 14, Alameda County Superior Court Judge Brad Seligman announced that Imerys Talc America Inc. was no longer a defendant in a trial involving claims filed on behalf of a dying woman suffering from cancer allegedly due to Johnson & Johnson's talcum powder. The jurors were instructed not to contemplate much on why the talc supplier was dropped from the trial.

Imerys Talc America Inc. and its affiliates, Imerys Talc Vermont and Imerys Talc Canada filed for Chapter 11 bankruptcy on Wednesday, February 13 in Delaware, amidst multi-million dollar lawsuits that allege that asbestos exposure from J&J's talcum powder cause ovarian cancer and mesothelioma. Imerys stated that it has been named as a defendant in more than 14,650 individual claims and is currently $100 million in debt resulting from fighting those cases. Until Thursday, Imerys was part of the trial involving a plaintiff's claims that J&J and multiple mining companies, owned by Imerys, were aware of the asbestos hazards for decades and yet failed to adequately warn the consumers. The trial is expected to go before the jury early in March.

Other defendants targeted in the talcum powder litigation are Colgate-Palmolive Co., Whittaker, Clark & Daniels, and Vanderbilt Minerals.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!